Diseases of the circulatory system. Ischemic heart diseases
Conditions
Interventions
Intervention 1: Intervention group: To this group will be given 250 mg capsules of Resveratrol ( 98% pure, AllNatural, Nutritional INC, Winnipeg, Canada). two times a day, morning and evening for
Sponsors
Boushehr University of Medical Sciences
Eligibility
Sex/Gender
All
Age
30 Years to 70 Years
Inclusion criteria
Inclusion criteria: Intention of the patients to participate in the trial Patients on elective surgery Having no addiction to any drugs or alcohol Not having mental or psychological disorders Participants with the age between 30 to 70 years
Exclusion criteria
Exclusion criteria: History of having chronic kidney disease, History of having chronic liver disease Having heart surgery before
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The heart function. Timepoint: Around 24 hours, before the start of Resveratrol consumption, and 12 to 24 hours after the period of 60 days of consumption. Method of measurement: By echocardiography.;Diastolic blood pressure. Timepoint: Around 24 hours, before the start of Resveratrol consumption, and 12 to 24 hours after the period of 60 days of consumption. Method of measurement: By sphygmomanometer, Mercury Type ( Microlife company).;Systolic blood pressure. Timepoint: Around 24 hours, before the start of Resveratrol consumption, and 12 to 24 hours after the period of 60 days of consumption. Method of measurement: By sphygmomanometer, Mercury Type ( Microlife company). | — |
Secondary
| Measure | Time frame |
|---|---|
| Total Antioxidant Capacity( TAC). Timepoint: ?Around 24 hours, before the start of Resveratrol consumption, and 24 to 72 hours after the period of 60 days of Resveratrol consumption. Method of measurement: By ELISA technique.;LDH (lactate dehydrogenase). Timepoint: ?Around 24 hours, before the start of Resveratrol consumption, and 24 to 72 hours after the period of 60 days of Resveratrol consumption. Method of measurement: By reliable kits( By using spectrophotometry).;TBRS. Timepoint: ?Around 24 hours, before the start of Resveratrol consumption, and 24 to 72 hours after the period of 60 days of Resveratrol consumption. Method of measurement: By ELISA technique.;CK-MB (creatine kinase MB). Timepoint: ?Around 24 hours, before the start of Resveratrol consumption, and 24 to 72 hours after the period of 60 days of Resveratrol consumption. Method of measurement: By reliable kits( By using spectrophotometry).;NO (Nitric oxide). Timepoint: ?Around 24 hours, before the start of Resveratrol consumption, and 24 to 72 hours after the period of 60 days of Resveratrol consumption. Method of measurement: By ELISA technique.;TNF-a (tumor necrosis factor-a). Timepoint: ?Around 24 hours, before the start of Resveratrol consumption, and 24 to 72 hours after the period of 60 days of Resveratrol consumption. Method of measurement: By ELISA technique.;Hs-CRP (High-sensitivity C-reactive Protein). Timepoint: ?Around 24 hours, before the start of Resveratrol consumption, and 24 to 72 hours after the period of 60 days of Resveratrol consumption. Method of measurement: By reliable kits( By using spectrophotometry). | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactAli Movahed
Boushehr University of Medical Sciences
Outcome results
None listed